NELA BioDynamics is a Spanish medtech company developing disruptive, modular intramedullary implants for joint and bone replacement. Their technology aims to improve patient recovery and surgical efficiency by avoiding traditional fixation methods.
NELA BioDynamics is a biomedical technology company based in Valencia, Spain, that develops modular orthopedic implants for joint and bone replacement. Founded in 2017 as a spinoff from the Polytechnic University of Valencia and the Health Research Institute of Valencia, the company utilizes patented technology designed to eliminate the need for traditional fixation methods, such as impact press-fit or bone cement. Their approach provides surgeons with control over the fixation force applied to the bone, aiming to modernize orthopedic surgical techniques that have remained largely unchanged for decades.
This technology addresses significant limitations in current orthopedic procedures by potentially reducing surgery times, minimizing traumatic tissue damage, and shortening post-operative recovery periods. By offering a customizable and less invasive solution, NELA BioDynamics aims to improve patient outcomes, enhance quality of life, and lower overall treatment costs, with the goal of transforming joint replacement procedures into more efficient, potentially ambulatory interventions. The company serves the medical device and medtech sectors, focusing on advanced endoprosthetic solutions for an aging and increasingly active patient population.